• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
Lower birthweight an independent risk factor for T2D: Study

Lower birthweight an independent risk factor for T2D: Study

It is also linked to diagnosis at a younger age, a lower prevalence of overweight/obesity, and fewer family members with a history of diabetes.


Warning over plan to bypass colleges for IMG assessment

Warning over plan to bypass colleges for IMG assessment

Long shadow of ‘Dr Death’ experience in Queensland prompts concern around proposal to sideline specialist colleges in favour of the AMC. 


$2b health funding program ‘fell short of ethical requirements’: ANAO

$2b health funding program ‘fell short of ethical requirements’: ANAO

Executive oversight, risk and fraud management were deficient, while many grants were ‘inconsistent’ with rules and guidelines.


RACGP issues warning over pathology takeover bid

RACGP issues warning over pathology takeover bid

A merger that would create Australia’s largest pathology business could be against the best interests of patients, the ACCC has been told.


RACGP opposes GLP-1 RA prescribing restrictions

RACGP opposes GLP-1 RA prescribing restrictions

Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs to negotiate, the PBS has been told.


Identifying the ripple effects of problem gambling

Identifying the ripple effects of problem gambling

GPs have ‘an amazing role’ in embedding discussion around risk and harms through routine assessments, says expert Dr Hester Wilson.


GLP-1 RA prescribing checks flagged

GLP-1 RA prescribing checks flagged

GPs may soon need Services Australia approval prior to prescribing the diabetes medications, following evidence of ‘high use’ outside of PBS restrictions.


Proportion of Level B attendances drops: AIHW

Proportion of Level B attendances drops: AIHW

While still the most common type of consultation, its use has plateaued despite overall GP attendances having increased.


Intermittent semaglutide availability until at least June

Intermittent semaglutide availability until at least June

Supply issues will remain while the medicine’s sponsor ‘continues to build stable stock supplies over coming weeks and months’.


In Practice: Managing tick-borne illnesses

In Practice: Managing tick-borne illnesses

The information is aimed to further support health professionals and patients to better understand tick-borne illness in Australia.


  • Previous
  • ...
  • 13
  • 14
  • 15
  • ...
  • Next
Pages: 13 of 36
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807